InsiderChief Financial Officer

Thomas Catinazzo Insider Trading Activity

Every SEC Form 4 transaction reported by Thomas Catinazzo, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Thomas Catinazzo buying or selling?

Thomas Catinazzo reported 0 open-market buys ($0) and 50 sells ($11.6M) across 50 Form 4 filings at 1 company — a net selling position of $11.6M.

Source: SEC EDGAR Form 4

Key Statistics (as of Oct 8, 2026)

Total Form 4 filings
50
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (50)
$11.6M

Insider sentiment

Net selling

Net insider flow of $11.6M in net selling, filed between Apr 1, 2021 – Oct 8, 2026.

Companies Thomas Catinazzo files for

#CompanyForm 4 filings
1RLAYRelay Therapeutics, Inc.50

Recent Thomas Catinazzo transactions

DateTickerRoleTypeSharesValueFiling
Oct 8, 2026RLAYChief Financial OfficerSale17.7K$329.3KSEC ↗
Sep 9, 2026RLAYChief Financial OfficerSale17.7K$335.6KSEC ↗
Aug 18, 2026RLAYChief Financial OfficerSale17.7K$349.7KSEC ↗
Jul 30, 2026RLAYChief Financial OfficerSale1.5K$27.2KSEC ↗
Jul 8, 2026RLAYChief Financial OfficerSale17.7K$331.1KSEC ↗
Jun 24, 2026RLAYChief Financial OfficerSale187.2K$3.2MSEC ↗
May 14, 2026RLAYChief Financial OfficerSale17.7K$227.8KSEC ↗
Apr 30, 2026RLAYChief Financial OfficerSale972$14.4KSEC ↗
Apr 10, 2026RLAYChief Financial OfficerSale19.5K$257.5KSEC ↗
Mar 11, 2026RLAYChief Financial OfficerSale17.7K$178.2KSEC ↗
Jan 29, 2026RLAYChief Financial OfficerSale15.5K$119.6KSEC ↗
Oct 30, 2025RLAYChief Financial OfficerSale21.7K$157.9KSEC ↗
Jul 30, 2025RLAYChief Financial OfficerSale20.1K$74.0KSEC ↗
May 1, 2025RLAYChief Financial OfficerSale19.2K$58.8KSEC ↗
Mar 31, 2025RLAYChief Financial OfficerSale4.9K$13.8KSEC ↗
Jan 31, 2025RLAYChief Financial OfficerSale58.9K$268.3KSEC ↗
Dec 31, 2024RLAYChief Financial OfficerSale4.9K$21.5KSEC ↗
Oct 30, 2024RLAYChief Financial OfficerSale9.1K$54.9KSEC ↗
Oct 1, 2024RLAYChief Financial OfficerSale6.5K$48.2KSEC ↗
Jul 31, 2024RLAYChief Financial OfficerSale10.8K$92.3KSEC ↗
Jul 1, 2024RLAYChief Financial OfficerSale9.4K$58.5KSEC ↗
Apr 30, 2024RLAYChief Financial OfficerSale1.7K$10.8KSEC ↗
Mar 29, 2024RLAYChief Financial OfficerSale348$2.7KSEC ↗
Jan 31, 2024RLAYChief Financial OfficerSale2.0K$19.3KSEC ↗
Dec 29, 2023RLAYChief Financial OfficerSale294$3.4KSEC ↗

Showing the 25 most recent filings of 50. Screen every filing.

Thomas Catinazzo insider trading FAQ

Is Thomas Catinazzo buying or selling?

Across 50 SEC Form 4 filings, Thomas Catinazzo reported 0 open-market purchases totaling $0 and 50 sales totaling $11.6M — a net selling position of $11.6M.

Which companies does Thomas Catinazzo file Form 4s for?

Thomas Catinazzo has reported insider transactions at 1 company, most often Relay Therapeutics, Inc. (RLAY).

How far back does Thomas Catinazzo's filing history go?

Trabud holds Thomas Catinazzo's SEC Form 4 filings from Apr 1, 2021 – Oct 8, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Thomas Catinazzo's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Thomas Catinazzo and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener